These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8388515)
21. Prevention of oncogenic viral infections in mice with CGP 11637, a synthetic muramyl dipeptide analog. Acevedo HF; Raikow RB; Acevedo HO; Delgado TF; Pardo M Antimicrob Agents Chemother; 1985 Nov; 28(5):589-96. PubMed ID: 3867329 [TBL] [Abstract][Full Text] [Related]
22. Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses. Corbin A; Sitbon M J Virol; 1993 Sep; 67(9):5146-52. PubMed ID: 8394442 [TBL] [Abstract][Full Text] [Related]
23. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference. Lavignon M; Evans L J Virol; 1996 Jun; 70(6):3852-62. PubMed ID: 8648721 [TBL] [Abstract][Full Text] [Related]
24. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia. Nazarov V; Hilbert D; Wolff L Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249 [TBL] [Abstract][Full Text] [Related]
25. Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv. Jones KS; Ruscetti S; Lilly F J Virol; 1988 Feb; 62(2):511-8. PubMed ID: 2826812 [TBL] [Abstract][Full Text] [Related]
26. Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice. Ostertag W; Vehmeyer K; Fagg B; Pragnell IB; Paetz W; Le Bousse MC; Smadja-Joffe F; Klein B; Jasmin C; Eisen H J Virol; 1980 Feb; 33(2):573-82. PubMed ID: 6251235 [TBL] [Abstract][Full Text] [Related]
27. Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells. Nishigaki K; Hanson C; Thompson D; Yugawa T; Ruscetti S J Virol; 2005 Oct; 79(20):12752-62. PubMed ID: 16188978 [TBL] [Abstract][Full Text] [Related]
28. Erythroid leukemia induced by Friend lymphatic leukemia virus in T-cell-depleted mice. Dawson PJ; Dresler SL; Fieldsteel AH Cancer Res; 1979 May; 39(5):1611-5. PubMed ID: 311686 [TBL] [Abstract][Full Text] [Related]
29. Effect of chronic ethanol consumption and retroviral infection on carcinogenesis and its possible inhibition by an immunostimulant, canthaxanthin: definition of a murine model. Mufti SI; Watson RR Prog Clin Biol Res; 1990; 325():283-304. PubMed ID: 2153985 [No Abstract] [Full Text] [Related]
30. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses. Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317 [TBL] [Abstract][Full Text] [Related]
31. Effective treatment of murine leukemia with antisense poly-2'O-(2,4-dinitrophenyl)-oligoribonucleotides. Wang A; Wang JH Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):43-51. PubMed ID: 10192288 [TBL] [Abstract][Full Text] [Related]
33. The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia. Wolff L; Ruscetti S J Virol; 1988 Jun; 62(6):2158-63. PubMed ID: 2835516 [TBL] [Abstract][Full Text] [Related]
34. Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia. Ishimoto A; Adachi A; Sakai K; Matsuyama M Virology; 1985 Feb; 141(1):30-42. PubMed ID: 3856371 [TBL] [Abstract][Full Text] [Related]
35. Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector. Kitagawa M; Aizawa S; Kamisaku H; Hirokawa K; Ikeda H Exp Hematol; 1999 Feb; 27(2):234-41. PubMed ID: 10029162 [TBL] [Abstract][Full Text] [Related]
36. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously. Sinkovics JG Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233 [TBL] [Abstract][Full Text] [Related]